Bioequivalence Protocols: In vivo/ In vitro studies

Both bioavailability and bioequivalence focus on the release of a drug substance from its dosage form and subsequent absorption into the systemic circulation. Bioavailability and Bioequivalence studies are required by regulations to ensure therapeutic equivalence between a pharmaceutically equivalent test product and a reference product. Several in vivo and in vitro methods are used to measure product quality.

 

  • Drug formulations
  • Fixed-dose combination products
  • Manufacturing drugs

Related Conference of Bioequivalence Protocols: In vivo/ In vitro studies

July 14-15, 2025

15th World Glycobiology Congress

Berlin, Germany
July 17-18, 2025

16th International Conference on Biofuels and Bioenergy

Amsterdam, Netherlands
September 08-09, 2025

23rd International Conference on Structural Biology

Frankfurt, Germany

Bioequivalence Protocols: In vivo/ In vitro studies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in